Skip to content
naulon

Not checkedNot checked for notices yet.

Successful treatment with bortezomib-containing regimen of primary plasma cell leukemia: a case report

Mohammad Bader Obeidat, Ali Mohammad Al-Swailmeen, Abdulmajeed Mohammad Arabeat and 1 more

The Pan African Medical Journal · 2020

doi:10.11604/pamj.2020.36.15.21717 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Plasma cell leukemia represents the most aggressive form of plasma cell dyscrasia.We report a 67-year old male with no previous medical illnesses presented with anemic symptoms. Blood film revealed 35% circulating plasma cells, bone marrow biopsy showed plasma cells constituting 85%. Diagnosis of primary plasma cell leukemia was completed. Induction chemotherapy with bortezomib, doxorubicin, and dexamethasone was started. After the first cycle, plasma cells in peripheral blood disappeared. The patient had complete remission at evaluation after the third cycle. Re-evaluation after the sixth cycle showed that he maintained remission. As he was non-transplant eligible, he was we kept on maintenance bortezomib. Twenty four months after the diagnosis, the patient remains in remission.

Abstract licence: CC BY

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.